A Clinical Study to Evaluate the Pharmacokinetics, Safety & Tolerability

Updated 06/21/2024

Status Completed

Clinical Trial Summary

The purpose of this study is to evaluate the pharmacokinetics, safety and tolerability of CKD-355.

Clinical Trial Description

An open-label, randomized, multiple-dosing parallel study to evaluate the pharmacokinetics, safety and tolerability of CKD-355 with D797 and D324 in healthy subjects ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03802162
Study type	Interventional
Source	Chong Kun Dang Pharmaceutical
Contact
Status	Completed
Phase	Phase 1
Start date	February 15, 2019
Completion date	August 31, 2019

See also
	Status	Clinical Trial	Phase
	Terminated	`NCT02503501` - Intranasal Glulisine in Amnestic Mild Cognitive Impairment and Probable Mild Alzheimer's Disease	Phase 2
	Recruiting	`NCT02854033` - Alzheimer's Disease Neuroimaging Initiative 3 (ADNI3)
	Completed	`NCT02681172` - Impact of FBB PET Amyloid Imaging in Change of Diagnosis in Patients With AD	Phase 4
	Completed	`NCT02593318` - Trial of Oxaloacetate in Alzheimer's Disease (TOAD)	Phase 1
	Completed	`NCT02264899` - MEMENTO-VAScular COmponents of Dementia	N/A
	Completed	`NCT02531360` - Evaluation of [18F]MNI-815 as a Potential PET Radioligand for Imaging Tau Protein in the Brain of Patients With Tauopathies	Phase 0
	Recruiting	`NCT04570761` - Effects of Auditory Brain Stimulation by "Pink Noise" on Memory Capacities in Alzheimer's Disease: Proof of Concept Study	N/A
	Not yet recruiting	`NCT05592678` - δ in Dementia Clinical Trials	Phase 2/Phase 3
	Not yet recruiting	`NCT05558709` - Social-cognitive Functioning: Validation of a New Neuropsychological Test	N/A
	Recruiting	`NCT05059158` - Amyloid-β Clearance Mechanisms in Alzheimer's Disease
	Recruiting	`NCT02832921` - Cognitive-motor Intervention Using Virtual Reality for Middle-aged Individuals at High Dementia Risk	N/A
	Completed	`NCT02370524` - Quantitative Evaluation of [18F]T807 as a Potential PET Radioligand for Imaging Tau in Patients With Alzheimer's Disease	Phase 1
	Completed	`NCT01780519` - The Cognitive Effects of Lorazepam in Healthy Older Individuals With TOMM40 Variable-length Polymorphisms	Phase 1
	Completed	`NCT02103894` - Evaluation of [18F]MNI-777 PET as a Marker of Tau Pathology in Subjects With Tauopathies Compared to Healthy Subjects	Phase 1
	Completed	`NCT01231971` - Alzheimer's Disease Neuroimaging Initiative 2
	Recruiting	`NCT05291234` - A Study to Assess Safety of ABBV-916 and How Intravenous ABBV-916 Moves Through Body and Affects Brain Amyloid Plaque Clearance in Adult Participants (Aged 50-90 Years) With Early Alzheimer's Disease	Phase 2
	Active, not recruiting	`NCT05771428` - Study to Assess Adverse Events, Change in Disease Activity and How Oral ABBV-552 Capsules Moves Through the Body of Participants Aged 50 to 90 Years With Mild Alzheimer's Disease	Phase 2
	Recruiting	`NCT06114745` - A Trial of SHR-1707 Infusion in Patients With Mild Cognitive Impairment Due to Alzheimer's Disease and Mild Alzheimer's Disease	Phase 1